Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Ultivue
AddedFeb 15, 2024
UpdatedJun 18, 2026
Ultivue

Ultivue

Series D

Ultivue, Inc.: Pioneering commercial physical and biological research since 2015.

HQ
Cambridge, MA, US
Founded
2015
Overview
Compare
Fundraising
Employees
Website

Founded in 2015, Ultivue, Inc. is dedicated to advancing commercial physical and biological research. The company's core mission is to empower scientists in the development of precision cancer therapies through innovative technologies. Ultivue offers ultrasensitive InSituPlex® assays and AI-driven spatial analysis tools that enable rapid, high-confidence insights into tissue samples. Their primary market focus is on providing solutions for profiling the immune landscape in tissues, thereby turning complex biological data into actionable insights.

Notable figures affiliated with Ultivue include leading scientists and industry experts who contribute to its pioneering research and development efforts. The company has attracted significant investment from prominent venture capital firms, bolstering its growth and innovation capacity. Key achievements include the successful deployment of InSituPlex® technology in numerous research settings, significantly accelerating the pace of cancer therapy development. Ultivue's impact is evident in its ability to provide researchers with unprecedented clarity and speed in biomarker analysis, ultimately enhancing the precision and effectiveness of cancer treatments.

Ultivue - Similar Companies

Altos Labs logo

Altos Labs

altoslabs.com

Zinnia Technologies logo

Zinnia Technologies

zinniatv.com

ClearLight Biotechnologies logo

ClearLight Biotechnologies

Upstream Bio logo

Upstream Bio

upstreambio.com

Illuminare Biotechnologies logo

Illuminare Biotechnologies

illuminarebio.com

Tuktu Care logo

Tuktu Care

tuktu.ca

Endolytix logo

Endolytix

Vivo logo

Vivo

teamvivo.com

Phenomix Sciences logo

Phenomix Sciences

Uvax Bio logo

Uvax Bio

uvaxbio.com

Affini-T Therapeutics logo

Affini-T Therapeutics

affinittx.com

Cambridge Technologies logo

Cambridge Technologies

Ontera logo

Ontera

ontera.bio

Limelight Bio logo

Limelight Bio

Xylyx Bio logo

Xylyx Bio

xylyxbio.com

Ultivue - Quick Facts

Who are Ultivue's competitors?

Companies similar to Ultivue include Altos Labs, Zinnia Technologies, ClearLight Biotechnologies and Upstream Bio.

When was Ultivue founded?

Ultivue was founded in 2015.

Where is Ultivue's headquarters located?

Ultivue's headquarters is located in Cambridge, MA, US.

When was Ultivue's last funding round?

Ultivue's most recent funding round was for $50M (USD) in April 2021.

How much has Ultivue raised to-date?

As of Apr 27, 2021, Ultivue has raised a total of $107.3M (USD).

How many employees does Ultivue have?

Ultivue has 56 employees as of Feb 5, 2024.

Ultivue - Classification

Ownership
  • Private
Technology
  • AI
Geographic Exposure
  • Global
Revenue
  • Recurring
  • Software
Customer
  • Enterprise
Main Product
  • Tissue Analysis
Tags
  • Biotech
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8730Research, Development, And Testing Services
  • 8731Commercial Physical and Biological Research
Show 13 more industry codes
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 620000Health Care and Social Assistance
  • 325000Chemical Manufacturing
  • 623000Nursing and Residential Care Facilities
  • 325410Pharmaceutical and Medicine Manufacturing
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 2800Chemicals And Allied Products
  • 8000Health Services
  • 2830Drugs
  • 8040Offices And Clinics Of Other Health Practitioners
  • 2834Pharmaceutical Preparations
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified